- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
Introgen Therapeutics, Inc.
(NASDAQ:INGN)Key Stats & Ratios
| Valuation | |
| Market Cap | 2.65M |
| P/E | — |
| P/E (Trailing) | -0.10 |
| P/E (Forward) | — |
| Price/Sales | 2.00 |
| Price/Book | 5.80 |
| EPS | -0.55 |
| EPS Growth (ttm) | — |
| Fiscal Year | |
| Fiscal Year Ends | Dec 31 |
| Last Quarter | Jun 2008 |
| Profitability | |
| Operating Income | -29499000.00 |
| Net Income | -24265000.00 |
| Profit Margin (ttm) | — |
| Operating Margin (ttm) | -26.67% |
| Management Effectiveness | |
| Return on Assets (ttm) | -225.00% |
| Return on Equity (ttm) | — |
| EBIT Margin (ttm) | — |
| SEC Filings | |
| Latest Form 10-Q (Quartely) | |
| Latest Form 10-K (Annual) | |
Financials
| Income Statement | |
| Total Enterprise Value | 3.25M |
| Revenue | 1.11M |
| Revenue/Share | 0.03 |
| Revenue Growth (ytd) | 17.50% |
| Annual Revenue Growth Rate (3Y) | -18.57% |
| Annual Income Growth Rate (3Y) | — |
| Earnings Growth (ytd) | — |
| Gross Operating Profit (ttm) | 2.08M |
| EBITDA | -28523000.00 |
| Diluted EPS (ttm) | -0.55 |
| Balance Sheet | |
| Total Cash | 6.18M |
| Total Cash/Share | 0.14 |
| Total Assets | 10.78M |
| Total Liabilities | 13.29M |
| Total Debt/Equity | 3.00 |
| Long Term Debt Common Equity Ratio | 2.96 |
| Current Ratio | 1.00 |
| Leverage Ratio | 6.00 |
| Book Value/Share | 0.05 |
| Cash Flow | |
| Cash Flow | -23289000.00 |
| Free Cash Flow | -15549000.00 |
| Cash Flow/Share | -0.53 |
| Free Cash Flow/Share | -0.35 |
Trading Information
| Stock Price History | |
| Beta | — |
| 52Wk Change | -98.50% |
| 52Wk Change Vs. Mkt | -98.00% |
| 52Wk High | 4.62 |
| 52Wk Low | 0.05 |
| 10 Day Moving Average | 0.21 |
| 200 Day Moving Average | 1.54 |
| Share Statistics | |
| Average Volume | 459.70K |
| Shares Outstanding | 44.14M |
| Shares Float | 38.02M |
| % Held by Insiders | 13.90% |
| % Held by Institutions | 24.80% |
| Shares Short (As of Nov 11, 2008) | 2.81M |
| Short Ratio | 28.00 |
| Short % of Float | 7.40% |
| Dividends & Splits | |
| Dividend Date | — |
| Dividend Yield | — |
| Dividend Amount | — |